Best Life Sciences Companies in Nebraska, United States
The 38 best Life Sciences companies in Nebraska, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Virtual Incision.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Nebraska
| # | Company | Last round | Disclosed funding | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Adjuvance Technologies Developer of saponin adjuvants and vaccines for infectious disease and immuno-oncology | — | — | — | David Gin Co-Founder | — | 15 patents Manufacturing triterpene saponin adjuvants for vaccines, including varicella‑zoster formulations. | — |
| 2 | ADS Biotec Manufactures of reagents and instruments for lab application | — | — | 35 | — | — | — | — |
| 3 | alivelock AliveLock is critical for medical & mental health professionals to provide the missing tool needed to monitor… | — | — | 4 | — | — | — | — |
| 4 | Allied Genetics Produces and supplies GMO seeds | — | — | — | Brian LIngle CEO | — | — | — |
| 5 | Anew Medical Developer of gene therapies for neurodegenerative disorders and cancer | — | — | — | Joseph Sinkule Founder & CEO | — | — | 2 partnerships |
| 6 | Anova Biosciences Developer of a genetic assay to identify stress resistance in beef cattle | — | — | — | William Julien CEO | — | — | — |
| 7 | BioProcess Algae Develops bioreactor integrated systems to process algae | — | — | 21 | Tim Burns Founder & CEO | — | 8 patents Algal bioprocesses converting stillage and biomass into biofuels via simultaneous saccharification‑fermentation | — |
| 8 | biosecurity technology BioSecurity Technology provides preventive measures to reduce the risk of transmission of infectious diseases. | — | — | 4 | — | — | 18 patents Patents concentrated in computing, sensing & instrumentation | — |
Top 12 Life Sciences companies in Nebraska
#1
Series B · Omaha, Nebraska · founded 2016 · 13 employees$17.9Mraised▾
Developer of a surgical drainage system. The Thoraguard is integrated with a software to notify the clinical staff for any leakages through an alarm. The system is integrated with sensors and software offers automated management for suction and tracks the drainage output rates. The system also has clog-free chest tubes.
- May 2025Series B$525K
- May 2025Conventional Debt—
- Nov 2023Series B$15M
- Nov 2017Seed$2.9M
#2
Series C · Lincoln, Nebraska · founded 2006 · 60 employees$127.2Mraised▾
Provider multi-quadrant surgery using miniature robots. The company offers MIRA(Miniaturized In vivo Robotic Assistant) a miniaturized surgical robotic support device. These robots would be equipped with tools and camera systems to operate within the abdominal cavity and could be inserted through a single tiny incision to perform minimally invasive surgeries, significantly reducing pain and recovery times for patients.
- Mar 2025Conventional Debt$7.9M
- Jun 2023Series C$30M
- Nov 2021Series C$46M
- Oct 2019Series B$20M
#3
Seed · Omaha, Nebraska · founded 2019 · 20 employees$2.8Mraised▾
Provider of AI-based image interpretation for MRI for prostate cancer detection. It offers Prostate ID software for the early diagnosis of cancer and COPD. It also offers radiologist interpretations, segmented prostate gland image sets, pathology laboratory results, correlation data, and others.
- Mar 2025Seed$200K
- Jan 2025Conventional Debt—
- Jan 2025Seed$280K
- Dec 2023Conventional Debt—
#4
Funding Raised · Lincoln, Nebraska · founded 2017 · 2 employees$2.8Mraised▾
Developer of prophylactic vaccines to treat neuroinvasive herpes virus. The vaccines are based on a neutered recombinant herpesvirus platform that eliminates a viral component R2 responsible for the transmission of these viruses into the nervous system and provides immune responses.
- Feb 2025Grant (prize money)$1.7M
- May 2023Grant (prize money)$960.6K
- Jul 2022Grant (prize money)$174.2K
#5
Funding Raised · Omaha, Nebraska · founded 2021$1.2Mraised▾
Developer of predictive multi-scale models for drug target discovery. It uses mechanistic computational models to accelerate and de-risk the process, moving beyond traditional one-drug-one-target approaches. The platform is also utilized in K-16 education to teach students about human health and diseases through hands-on modeling. This allows biologists to generate hypotheses, pharmaceutical teams to collaborate on drug target discovery, and computational biologists to integrate insights with high-throughput data. Students learn biology and disease processes by building and simulating models. The company also assists pharma and biotech companies in accelerating and reducing the cost of drug discovery by building comprehensive models of diseases and identifying novel drug targets. Furthermore, it focuses on reprogramming the human immune system by deciphering its complexities and developing novel treatments.
- Sep 2024Grant (prize money)$906.8K
- May 2022Grant (prize money)$250.5K
#6
Series A · Lincoln, Nebraska · founded 2014 · 6 employees$6.7Mraised▾
Developer of epigenetic crop breeding technology for yield and resilience. The technology enhances crop performance through epigenetic modification, without genetic modification. It combines crop epigenetic variation with computational science to identify optimal lines. The technology aims to improve traits like heat resistance, cold tolerance, and growth in marginal soils.
- Mar 2021Series A$350K
- Mar 2021Conventional Debt—
- Sep 2017Grant (prize money)$600K
- Mar 2017Series A$3.2M
#7
Seed · Lincoln, Nebraska · founded 2017 · 2 employees$250Kraised▾
Biotech developing non-addictive therapies for pain and neurodegenerative diseases. They are focused on creating novel drug technologies to safely target neurodegeneration and pain without the risk of addiction or systemic side effects. Their APOLLO platform delivers engineered proteins to neurons, disrupting pain signals from sensory nerve cells while leaving motor nerves untouched. Their lead asset, N-001, is designed to treat pain's physiological symptoms without systemic absorption or invasive procedures. They also have a secondary asset, NL-17, for migraine prevention, offering prolonged relief without addiction risk or sensory loss. They are also working on N-19a for chronic pain, with the potential to heal the cause of pain. Their pipeline includes targeted therapeutics for various conditions, including pain, migraine, and Alzheimer's. They are committed to providing life quality without side effects like addiction, nausea, and dizziness. They are involved in research, development, and innovation in the biotechnology and pharmaceutical industries, with a focus on creating non-addictive pain management solutions.
- Sep 2023Grant (prize money)$2.8M
- Sep 2020Grant (prize money)$243.8K
- Apr 2018Seed$250K
#8
Funding Raised · Omaha, Nebraska · founded 2024$1.9Mraised▾
Developer of novel pharmaceutical products for musculoskeletal disorders. This company focuses on discovering, developing, and marketing pharmaceutical products to alleviate pain and promote healing in patients with osteoarthritis and related conditions. The emphasis is on creating treatments with minimal side effects. Their work involves the clinical translation of novel therapeutic interventions.
- May 2020Grant (prize money)$1.9M
#9
Funding Raised · Lincoln, Nebraska · founded 2013 · 14 employees$576.2Kraised▾
Provider of fall detection and prevention device for patients. The company has developed technology that uses 3D motion detection and artificial intelligence to provide a complete understanding of the patient and the entire hospital room. It sees the patient and monitors their behavior constantly and consistently. It helps in preventing falls and assists healthcare staff in managing the well-being of patients.
- Sep 2020Grant (prize money)$114.2K
- Aug 2020Grant (prize money)$202K
- May 2016Conventional Debt$260K
#10
Seed · Omaha, Nebraska · founded 2001 · 2 employees$300Kraised▾
Provider of custom-made brackets for braces to align teeth. It provides orthodontists products like brackets containing elastics in different colors. The company has three different products disney, signature, and college. The company also offers an online listing platform for dentists. For Orthodontists company helps in increasing patient revenue and experience.
- Feb 2021Seed$300K
#11
Deadpooled · Omaha, Nebraska · founded 2012$500Kraised▾
Trak Surgical manufactures surgical devices including the Traker Guided Surgical System for joint replacement surgery which is a jig free, computer-assisted system for joint replacement that allows surgeons freehand bone cutting with real-time 3D graphical feedback from navigation.
- 2013Seed$500K
#12
Seed · Omaha, Nebraska · founded 2012 · 3 employees$245.8Kraised▾
Orion BioScience, an early stage company is focused on developing a platform technology capable of targeting a wide range of autoimmune diseases using a Soluble Antigen Array (SAgA) platform and ORNx formulation technology. Its lead product is a Soluble Antigen Array (SAgA) therapeutic which is being developed to clear NMO-IgG antibody in patients with neuromyelitis optica (NMO) (preclinical). SAgAs act as an 'allergy shot' for autoimmunity as they provide a multivalent display of one or more disease-specific antigen signals along a flexible polymer
- Oct 2018Seed—
- Jul 2014Grant (prize money)$245.8K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Nebraska is moving
A read on the academic research around Biotechnology in Nebraska — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 47 papers.
- University of Nebraska–Lincoln30
- University of Nebraska Medical Center18
- Nebraska Medical Center8
- University of Nebraska at Omaha2
- University of Nebraska at Kearney1
- Cell culture4
- Genome3
- Virus2
- Western blot2
- Enzyme2
- Lignin2
- Metabolomics2
- Agriculture2
- Crop2
- Sorghum2
- DNA polymerase2
- Polymerase2
- DNA damage1
- DNA repair1
- Cell cycle1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.